Poor Sleep Raises Risk of Dyskinesia With Parkinson’s, Study Finds
Poor sleep quality is a key factor in developing dyskinesia, the uncontrolled and involuntary movements that can affect people with …
Articles by Andrea Lobo
New Method Devised to Generate Dopaminergic Neurons
Researchers have devised a new method to generate dopamine-producing neurons from skin cells of Parkinson’s disease patients, a process…
Servier Licenses LRRK2 Inhibitor, Phase 1 Trial to Start by Year’s End
Servier is set to launch a Phase 1 clinical trial in healthy volunteers to investigate an LRRK2 inhibitor, developed in…
Survival With Parkinson’s Tied to Age at Onset, Cognition in Study
Older age at onset, a faster rate of disease progression, and severe cognitive impairment are key factors in poorer survival…
At-home Gait Monitor May Track Progression, Treatment Response
Continuously monitoring the gait of Parkinson’s disease patients in their homes using a wireless device is feasible and may…
MJFF and Edmond J. Safra Foundation Expand Network
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) announced it will expand the number and reach of…
Raised Disease Risk Tied to Early, Midlife Hospital-treated Infections
A new study suggests that infections requiring specialty hospital care are associated with an increased risk of developing Parkinson’s…
Phase 1/2 Trial Supports Ketamine for Levodopa-induced Dyskinesia
New trial data suggest that low-dose ketamine — which does not induce anesthesia — may be a potential treatment for…
New Phase 3 Trial Data Back P2B001 as Therapy for Early Parkinson’s
New trial data suggest that the combination therapy P2B001 for early Parkinson’s disease may offer effective symptom control…